Comparison of the efficacy of local thermotherapy versus Glucantime® in the treatment of anthroponotic cutaneous leishmaniasis: a pilot study
Open Access
- 11 September 2025
- journal article
- research article
- Published by Springer Nature in Parasitology Research
- Vol. 124 (9) , 1-7
Abstract
This pilot study is the first in Iran that evaluates the effectiveness of thermotherapy compared to intralesional Glucantime® in the treatment of cutaneous leishmaniasis caused by Leishmania tropica. Forty patients with cutaneous leishmaniasis were separated into two groups, each consisting of 20 patients. The control group received intralesional Glucantime® weekly for 8 weeks, while the other group received a single session of thermotherapy for each lesion using ThermoMedTM model 1.8. The patients were monitored for 6 months, during which the outcomes were evaluated by considering the dimensions, consistency, and rates of remission of the lesions. The terms “initial remission” and “complete remission” were clearly defined, and any instances of therapy failure were documented. The statistical analysis was conducted using SPSS 24.0, employing independent t-tests, chi-square tests, and ANOVA. Both treatment groups exhibited considerable decreases in lesion size and enhanced texture, with no statistically significant differences. Nevertheless, the group that underwent thermotherapy demonstrated a more significant decrease in lesion size and improvement in texture after 6 months. The remission rates were similar; however, Glucantime® achieved a faster remission. No significant side effects were recorded in either group. The present study showed that thermotherapy was equally effective as intralesional Glucantime® in treating anthroponotic leishmaniasis. Thermotherapy can be considered as an alternative, especially when Glucantime® cannot be used, even though it requires further research. Graphical abstractKeywords
Funding Information
- Mashhad University of Medical Sciences (930460)
This publication has 16 references indexed in Scilit:
- World Medical Association Declaration of HelsinkiJAMA, 2025
- Pilot evaluation of thymol-loaded chitosan gel as a complementary topical therapy for cutaneous leishmaniasisCarbohydrate Polymer Technologies and Applications, 2024
- A phase II multicenter randomized study to evaluate the safety and efficacy of combining thermotherapy and a short course of miltefosine for the treatment of uncomplicated cutaneous leishmaniasis in the New WorldPLOS Neglected Tropical Diseases, 2022
- Leishmaniasis: the act of transmissionTrends in Parasitology, 2021
- Molecular signatures of anthroponotic cutaneous leishmaniasis in the lesions of patients infected with Leishmania tropicaScientific Reports, 2020
- Thermoterapy effective and safer than miltefosine in the treatment of cutaneous leishmaniasis in ColombiaRevista do Instituto de Medicina Tropical de São Paulo, 2013
- Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniateClinical and Experimental Dermatology, 2007
- Heat therapy for cutaneous leishmaniasis elicits a systemic cytokine response similar to that of antimonial (Glucantime) therapyTransactions of the Royal Society of Tropical Medicine and Hygiene, 2006
- Nível de conhecimentos sobre Leishmaniose Tegumentar Americana (LTA) e uso de terapias alternativas por populações de uma área endêmica da Amazônia do Maranhão, BrasilCadernos de Saude Publica, 2002
- Leishmaniosis cutánea en Colombia y géneroCadernos de Saude Publica, 2001